VIAGRA (sildénafil) - Erectile dysfunction
Opinions on drugs -
Posted on
Dec 02 2024
Reason for request
First listing
Summary of opinion
Favourable opinion for reimbursement only in adult men with erectile dysfunction related to one of the following conditions:
- Paraplegia and tetraplegia of any origin;
- Pelvic injuries complicated by urinary disorders;
- Sequelae of surgery (aortic aneurysm; radical prostatectomy, total cystectomy and colorectal resection) or abdominopelvic radiotherapy;
- Sequelae of priapism;
- Known diabetic neuropathy;
- Multiple sclerosis;
And those with erectile dysfunction due to long-term antipsychotic treatment.
No clinical added value compared to other medicinal products containing sildenafil.
Clinical Benefit
Substantial |
The clinical benefit of VIAGRA (sildenafil) 50 mg orodispersible film is substantial only in adult men with erectile dysfunction related to one of the following conditions:
|
Insufficient |
Clinical Added Value
no clinical added value |
These medicinal products are a range supplement that do not provide any clinical added value (CAV V) compared to the forms already listed. |
Documents
English version
Contact Us
Évaluation des médicaments